Outcome measures in psoriatic arthritis: Where next?-Reference-Cited by-同舟云学术

Outcome measures in psoriatic arthritis: Where next?

Published:2022-11 Issue:S1 Volume:20 Page:
ISSN:1478-2189
Container-title:Musculoskeletal Care
language:en
Short-container-title:Musculoskeletal Care

Author:

Hackett Simon¹,Coates Laura C.¹

Affiliation:

1. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences University of Oxford Botnar Research Centre Oxford UK

Funder

National Institute for Health Research

Publisher

Wiley

Subject

Nursing (miscellaneous),Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine,Chiropractics,Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/msc.1692

Reference71 articles.

1. Interleukin‐6 and soluble interleukin‐2 receptor alpha‐markers of inflammation in patients with psoriatic arthritis?;Alenius G. M.;Clinical & Experimental Rheumatology,2009

2. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis;Medicina;2024-09-04

2. Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy;Rheumatology Science and Practice;2024-04-28

3. Management of psoriatic arthritis: a consensus opinion by expert rheumatologists;Frontiers in Medicine;2023-11-30

4. Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study;Journal of Clinical Medicine;2023-06-07